Search PubMed⌕ Search

Biomedical subjects

M Y Chan

Publications and source records attributed to M Y Chan.

72 records · Page 4Linked to original sources

Studies on the kinetics of melatonin and N-acetylserotonin in the rat at mid-light and mid-dark.

The distribution and disappearance of melatonin and N-acetylserotonin after intravenous injection were studied at mid-light and mid-dark. Male rats were adapted under a photoperiod of 12 h light and 12 h dark cycle for a minimum of 1 week. After the intravenous injection of melatonin (10 micrograms), N-acetylserotonin (10 micrograms), or 3H-melatonin (76 ng), blood samples were collected at 1, 3, 5, 10, 20, 30, 45, 60, 75, 90, and 120 min. The concentrations of indoles in the plasma samples were determined by radioimmunoassay, while the radioactivity of 3H-melatonin was determined by scintillation counting. The distribution of melatonin and N-acetylserotonin followed a two-compartment model, showing an initial distribution phase followed by an elimination phase. The biological half-life of melatonin at mid-light and mid-dark were similar but the volume of distribution (V beta and Vc) and metabolic clearance rate (C1s) were greater at mid-dark than at mid-light. The estimated melatonin secretory rate at mid-dark was fivefold greater than that at mid-light. When 3H-melatonin was used, the half-life was significantly longer. A diurnal difference in the distribution was also evident in the N-acetylserotonin studies. The volume of distribution (V beta and Vc) was greater at mid-dark while the C1s was not significantly faster at mid-dark compared with that at mid-light. However, the estimated N-acetylserotonin secretory rate at mid-dark was eightfold greater than at mid-light.

Animals↗

Effects of naloxone on serum corticosterone and gastric lesions in stressed rats.

In rats subjected to restraint and exposure to cold, naloxone did not significantly influence the increased serum concentrations of corticosterone or the incidence of stress ulceration, but it significantly reduced the severity of gastric lesions. These findings suggest that endogenous opioids released during stress may contribute to the pathogenesis of stress ulceration. They also support the theory that the adrenocorticosteroids are unimportant aetiological factors in stress ulcer formation.

Animals↗

A comparison of the pharmacodynamic profiles of nomifensine and amitriptyline in normal subjects.

1 Six healthy male volunteers participated in a double-blind placebo crossover comparison of the pharmacodynamic profiles of single oral doses of 75 mg nomifensine and 50 mg amitriptyline. 2 Nomifensine treatment did not influence salivary flow and did not significantly affect psychomotor performance (critical flicker fusion, pursuit rotor and reaction time): in addition nomifensine had no significant effect on subjective measurements of sedation and concentration. 3 By contrast, amitriptyline treatment significantly reduced salivary flow and was associated with significant sedation and reduced concentration: significant changes in psychomotor performance were also noted. 4 Plasma concentrations of amitriptyline and nomifensine were measured at 2 h. The respective median concentration values were 55.0 ng/ml and 52.0 ng/ml. 5 Ex vivo platelet amine uptake of dopamine (DA) and 5-hydroxytryptamine (5HT) was measured 2 h after each treatment. Both nomifensine and amitriptyline treatment significantly inhibited DA uptake to a similar extent. Amitriptyline treatment additionally inhibited 5-HT uptake.

Amitriptyline↗

The effect of berberine on bilirubin excretion in the rat.

Berberine-containing herbs have been used in folk medicine to relieve neonatal jaundice. In the present investigation, the acute and chronic effects of berberine on bilirubin excretion were studied in rats. Acute doses of berberine were found to increase the secretion of bilirubin in experimental hyperbilrubinemia without affecting the UDP-glucuronyltransferase activity and BSP clearance. Continuous treatment abolished this effect. This apparent tolerance could be attributed to the inhibitory action of chronic berberine treatment on UDP-glucuronyltransferase activity, but the mechanism of this inhibition was not elucidated. Liver microsomal protein concentration, ethylmorphine N-demethylation, and BSP clearance were unchanged.

Animals↗

Morphine treatment and intravenous glucose tolerance tests in mice.

The effect of acute and chronic morphine treatment on i.v. glucose tolerance tests in mice was investigated. It was found that neither acute nor chronic morphine treatment affected the serum glucose disappearance with time after i.v. glucose loading, indicating that morphine has no significant effect on glucose tolerance. Analysis of hepatic glycogen and glucose levels in these mice revealed that morphine treatment might have some effects on glucose metabolism, but at the analgesic dose employed, did not impair the animal's physiological response to i.v. glucose loading.

Animals↗

Pharmacokinetics of fluconazole in children requiring peritoneal dialysis.

After major open heart surgery, a significant number of infants and children are dependent on peritoneal dialysis as a result of renal impairment. They often require broad-spectrum antibiotics for the treatment of ongoing infections or as prophylactic therapy and have an increased risk of fungal infection. Fluconazole is a new thiazole antifungal agent that has been widely used in adults, but its use in children with acute renal impairment requiring peritoneal dialysis has not been documented. The purpose of this investigation was to study the pharmacokinetics of fluconazole in infants and children who developed various degrees of renal impairment, with or without the need for peritoneal dialysis, after major open heart surgery. Between January 1992 and June 1995, 17 children ranging in age from 2 weeks to 3 years (mean, 6 months) who received fluconazole therapy intravenously (3 mg/kg per day for 2 to 3 weeks) after major open heart surgery were enrolled in a prospective study. They were divided into two groups--those who required peritoneal dialysis (PD group; n = 8) and those who did not (non-PD group; n = 9). Blood, urine, and peritoneal dialysate samples were collected for 4 days to determine the pharmacokinetics of the drug, and data were compared between the two groups. The two groups of children had similar demographic characteristics, and their plasma concentrations of fluconazole showed no statistically significant differences. For children dependent on peritoneal dialysis, fluconazole was excreted almost solely through dialysis. Despite a significantly longer terminal elimination half-life for this group of infants, they tended to have a marginally larger volume of distribution of the drug. This, coupled with the continuous hourly exchange of dialysate, provided a large sink volume to effectively remove flu- conazole from the circulation. Thus the plasma clearance and the accumulation ratio were comparable for the two groups of children. Continuous cycling peritoneal dialysis effectively removed fluconazole from the circulation and was the main mode of excretion of the drug in children dependent on dialysis.

Antifungal Agents↗

The menstrual cycle and platelet 5-HT uptake.

The association between the onset of depressive illness and the paramenstruum has been reported. In the present study, we looked at changes in platelet 5-HT uptake in six healthy, regularly menstruating subjects on days 1, 10, and 24 of three consecutive menstrual cycles to explore possible biochemical bases for mood changes associated with menstruation. Platelet 5-hydroxytryptamine (5-HT) uptake was determined by suspension of platelet pellets in 0.5-5 microM hydroxy [G-3H] tryptamine [( 3H]-5-HT) creatinine sulfate solution at 37 degrees C and measurement of radioactivity of [3H]-5-HT in the platelets using liquid scintillation counting. Mood changes were measured using the Moos Menstruation Distress Questionnaire and the Spielberger State Anxiety Scale. Analysis of variance and trend analysis revealed significant elevation of Km and Vmax on day 24 of the cycle, which was consistent across the three menstrual cycles studied. A significant linear rise of "negative affect" across each cycle peaking on day 1 was detected. "Water retention" and "behavioral change" also peaked on day 1. No significant correlation, however, was obtained between the mood scores and platelet 5-HT uptake. These findings are discussed.

Adult↗

The effect of some centrally active drugs on corticosterone secretion and metabolism in rats.

1. Male rats were treated with morphine sulphate (10 mg/kg), methadone (10 mg/kg) and chlorpromazine (8.0 mg/kg) respectively, for 2 weeks. 2. At the end of this period, the adrenal glands of treated rats had increased in weight. 3. The concentration of corticosterone in the peripheral plasma was significantly lowered in the chlorpromazine-treated rats, increased in the methadone-treated rats and was unchanged in the morphine-treated rats. 4. The metabolic clearance rate of [1,2-3H]corticosterone decreased in the chlorpromazine-treated rats, while only a slight reduction was observed with methadone treatment. 5. These results showed that chronic treatment with either morphine or methadone did not suppress the adrenal function. The possible site of action of chlorpromazine in suppressing corticosterone secretion is discussed.

Adrenal Glands↗

The effect of long-term chlorpromazine and desipramine treatment on adrenal corticosterone, cyclic AMP, and cholesterol distribution in rats.

1. Male rats were injected intraperitoneally with chlorpromazine (10 mg/kg) and desipramine (10 mg/kg), respectively, twice daily for 2 weeks. 2. The adrenal corticosterone concentrations were significantly lowered in chlorpromazine- and desipramine-treated rats. 3. Large dose of corticotrophin would increase the adrenal corticosterone level in chlorpromazine-treated but the adrenal response was significantly less than in the untreated controls. 4. The adrenal cyclic AMP level was similar in treated and control rats and the adrenal response to corticotrophin was not decreased at the cyclic AMP level. 5. The cholesteryl ester concentrations in the adrenals were significantly increased by drug treatment, although the free cholesterol concentrations were unchanged in the cytosol and mitochondrial cell fractions. 6. The possible site of action of chlorpromazine in suppressing corticosterone production is discussed.

Adrenal Glands↗

Effects of adrenalectomy and adrenal steroids on the uptake of serotonin in rat platelets.

Changes induced by adrenalectomy, triamcinolone treatment and deoxycorticosterone (DOC) treatment on the uptake of [3H]-serotonin into platelets were studied ex vivo, using rat platelets suspended in physiological medium. Adrenalectomy caused a decrease in active uptake of serotonin and an associated increase in apparent Km. Treatment of the adrenalectomized rats with triamcinolone (0.25 mg/kg), but not DOC (1.0 mg/kg) restored the active uptake of serotonin. At triamcinolone dose of 0.5 mg/kg, the serotonin uptake was raised to a level that was significantly higher than normal. Kinetic analysis of uptake data showed the apparent Km to be affected by both triamcinolone and DOC, while the apparent Vmax of uptake rate was increased by triamcinolone treatment.

Adrenal Cortex Hormones↗

Further studies on the effects of adrenal steroids in the active transport of serotonin into rat platelets.

Male rats were treated with a fixed dose of aminoglutethimide (50 mg/kg s.c.) or with progressively increasing doses (50-100 mg/kg s.c.) for 3 days. Corticosterone levels were found to be decreased in the latter group. Platelet uptake of serotonin as well as the apparent Vmax were decreased, whereas the Km of uptake were increased when compared with that of the control group. Addition of ACTH (10 iu/dl) to control rat platelet and corticosterone (10-80 micrograms/dl) or triamcinolone (0.5-5.0 micrograms/dl) to adrenalectomized rat platelet suspension in vitro did not increase the serotonin uptake of the preparation. Administration of exogenous dexamethasone (0.05-0.2 mg/kg i.m.) or triamcinolone (0.05-5.0 mg/kg i.m.) to adrenalectomized rats, caused a dose related increase in active uptake of serotonin by the platelets. Deoxycorticosterone (0.1-1.0 mg/kg i.m.) did not have this effect. The time course of response to, and the maximum percentage increase in platelet serotonin uptake by, exogenous corticosteroids are related to their glucocorticoid potency. The possible role of glucocorticoids on platelet serotonin uptake process is discussed.

Adrenalectomy↗